Showing results (51-60 of 252) with videos related to
Sort By:
Pageof 26
Cell Adhesion & Migration|October 9, 2018
Continuous, label-free, 96-well-based determination of cell migration using confluence measurementChristian Mayr, Marlena Beyreis, Heidemarie Dobias, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 3, 2018
The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancerTarkan Jäger, Daniel Neureiter, Mohammad Fallaha, et al.Anticancer Research|August 9, 2015
3-Deazaneplanocin A May Directly Target Putative Cancer Stem Cells in Biliary Tract CancerChristian Mayr, Andrej Wagner, Angelika Stoecklinger, et al.International Journal of Molecular Sciences|September 19, 2018
HDAC-Linked "Proliferative" miRNA Expression Pattern in Pancreatic Neuroendocrine TumorsEckhard Klieser, Romana Urbas, Stefan Swierczynski, et al.Anticancer Research|October 28, 2015
Endoplasmic Reticulum Stress in Pancreatic Neuroendocrine Tumors is Linked to Clinicopathological Parameters and Possible Epigenetic RegulationsEckhard Klieser, Romana Illig, Stefan Státtner, et al.Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|April 6, 2013
Photodynamic therapy for hilar bile duct cancer: clinical evidence for improved tumoricidal tissue penetration by temoporfinAndrej Wagner, Tobias Kiesslich, Daniel Neureiter, et al.Oncotarget|December 2, 2015
The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cellsChristian Mayr, Andrej Wagner, Magdalena Loeffelberger, et al.Endoscopy International Open|September 9, 2022
New method for real-time visualization and quantitative characterization of early colorectal cancer in endoscopy: a pilot studyAndrej Wagner, Stephan Zandanell, Alexander Ziachehabi, et al.Cancers|August 7, 2021
HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract CancerChristian Mayr, Tobias Kiesslich, Sara Erber, et al.Cells|February 26, 2020
Expression of the microRNA-200 Family, microRNA-205, and Markers of Epithelial-Mesenchymal Transition as Predictors for Endoscopic Submucosal Dissection over Esophagectomy in Esophageal Adenocarcinoma: A Single-Center ExperienceDaniel Neureiter, Christian Mayr, Paul Winkelmann, et al.Pageof 26